1. Centre d'Investigations Cliniques Plurithématique 1433, INSERM, Université de Lorraine, Nancy, France; F‐CRIN INI‐CRCT (Cardiovascular and Renal Clinical Trialists), INSERM U1116, Centre Hospitalier Régional Universitaire de Nancy, Nancy, France
2. UnIC@RISE, Cardiovascular Research and Development Center, Department of Surgery and Physiology Faculty of Medicine of the University of Porto Porto Portugal
3. Imperial College London, London, UK; Baylor Heart and Vascular Institute Baylor University Medical Center Dallas TX USA
4. Institute of Cardiovascular and Medical Sciences University of Glasgow Glasgow UK
5. Baylor Scott and White Research Institute Dallas, TX, USA
6. Dallas, TX, USA; University of Mississippi Medical Center Jackson MS USA
7. Boehringer Ingelheim Pharma GmbH & Co. KG Biberach Germany
8. Boehringer Ingelheim Pharma GmbH & Co. KG Ingelheim Germany
9. Boehringer Ingelheim International GmbH Ingelheim Germany
10. Roche Diagnostics International Ltd Rotkreuz Switzerland
11. London School of Hygiene and Tropical Medicine London UK
12. Department of Cardiology (CVK) of German Heart Center Charité; Institute of Health Center for Regenerative Therapies (BCRT), German Centre for Cardiovascular Research (DZHK) partner site Berlin Charité Universitätsmedizin Berlin Germany
13. Université de Lorraine Centre d'Investigations Cliniques Plurithématique 1433, INSERM, CHRU Nancy France
14. Massachusetts General Hospital and Baim Institute for Clinical Research Boston MA USA